Recent news
12 Jun 2017

Cerba Healthcare and VitaDX sign a partnership to validate...

Cerba Healthcare and VitaDX sign a partnership to validate the VisioCyt® test for the early diagnosis of bladder cancer.

CP_Cerba_VitaDX_EN.pdf
20 Apr 2017

Finalization of shareholder change

Partners Group and PSP Investments have finalized the acquisition of Cerba HealthCare, a leading European operator of clinical pathology laboratories, from PAI Partners.

PR_Closing_Cerba_Healthcare_EN.pdf
30 Mar 2017

Cerberus Nightingale 1

Notice of redemption

Cerberus_Nightingale_Notice_of_Redemption.pdf
See all news